Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/30c9cbcb-02f8-438f-90e7-b31d014d51ef/transcript

IBM CEO Arvind Krishna discusses IBM's $11 billion acquisition of Confluent. Krishna also spoke about the impact of AI, his expectation for IBM to pursue more AI deals, the regulatory environment for those deals, and how AI is a tailwind for the company, causing no net decrease in workers. Krishna spoke with Bloomberg's Caroline Hyde.

IBM CEO Arvind Krishna discusses IBM's $11 billion acquisition of Confluent. Krishna also spoke about the impact of AI, his expectation for IBM to pursue more AI deals, the regulatory environment for those deals, and how AI is a tailwind for the company, causing no net decrease in workers. Krishna spoke with Bloomberg's Caroline Hyde.

IBM CEO Talks Confluent Acquisition and AI Impact

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/cdff6cb1-6d7c-470b-bb68-b410011ffa7f/transcript

Strategas Research Partners Chairman and CEO Jason Trennert discusses his book, the purpose of the financial services industry, the potential challenge of private credit to the future, and the effect of geopolitical risk. Trennert spoke with Bloomberg's Tom Keene and Paul Sweeney.

Strategas Research Partners Chairman and CEO Jason Trennert discusses his book, the purpose of the financial services industry, the potential challenge of private credit to the future, and the effect of geopolitical risk. Trennert spoke with Bloomberg's Tom Keene and Paul Sweeney.

Strategas Research Partners CEO Talks Financial Services

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/be1c4553-295e-4097-a776-b410011dc697/transcript

US Secretary of the Interior Doug Burgum says the Trump administration is taking steps to increase US energy production amid the war in Iran. He speaks on "Balance of Power: Evening Edition."

US Secretary of the Interior Doug Burgum says the Trump administration is taking steps to increase US energy production amid the war in Iran. He speaks on "Balance of Power: Evening Edition."

US Interior Secretary Doug Burgum Talks US Energy Production

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a71b73ed-ab22-4da9-8831-b40c016d07cc/transcript

Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips